Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx

Warning LetterOpen

Puerto RicoFEI 2650148Issued Jul 16, 2018

View FDA's record for FEI 2650148

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 2650148.

Violations0

Issue DateJul 16, 2018

Product TypeOther

StatusOpen

Letter Details

Firm: Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx
Location: Puerto Rico
FEI Number: 2650148
Country: Puerto Rico
Issue Date: July 16, 2018
Issuing Office: N/A
Product Type: Other
Status: Open

Summary

Based on limited metadata, the FDA issued a Warning Letter to Lopez Gonzalez Santana Corporation (operating as Domel and Dermixx) on July 16, 2018, regarding products classified as "Other." Without access to the full letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is not specified in the metadata, limiting clarity on which FDA division initiated the warning. To understand the complete scope and details of the violations, the full Warning Letter text would need to be reviewed.

Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx FDA Warning Letter, July 16, 2018